Rapid Local Recurrence of an Extraventricular Neurocytoma That Had Disappeared after Gamma Knife Radiosurgery.
Zhu Jun-ming,Zhao Yuan-yuan,Feng Fang,Fu Wei-ming,Zhang Jian-min,Ma Jie,Zhao Zhong-sheng,Lu Gang
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20122375
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Central neurocytoma (CN), first described by Hassoun et al in 1982, is a rare neuronal tumor of the central nervous system, and accounts for 0.25%-0.5% of all intracranial tumors. CN commonly occurs as an intraventricular mass but may also occur as a periventricular parenchymal mass or even in locations remote from the ventricles, in which case it is termed as an extraventricular neurocytoma (EVN) (cerebral). EVNs show a wide variability with regard to morphologic features, cellularity, and proliferation rate and are more frequently associated with poorer clinical outcomes than CNs. 1 To our knowledge, little is known regarding the treatment of atypical neurocytomas. In September 2008, a 78-year-old man was admitted to the neurosurgery department in our hospital because of a partial seizure. He had refractory epilepsy since 10 years before. On admission, his neurological and physical examinations yielded normal results. On performing ictal electroencephalography, the clinical-neurophysiological data indicated an epileptogenic zone involving the left anterior temporal lobe. The neuropsychological study showed normal. A computerized tomography (CT) scan showed a well-circumscribed, complex, cystic and solid mass lesion (3.5 cm × 3.5 cm) with extratumoral mural nodules in the left temporal lobe without peritumoral edema. The tumor and the lateral ventricle were not connected. Compared to the gray matter in the left temporal mesial lobe, the lesion was found to be hyperintense on T2-weighted fluid-attenuated inversion recovery MRI scans and slightly hypointense on T1-weighted images (Figure 1A). The lesion involved the uncus-amygdala and a part of the hippocampus and showed enhancement after gadolinium injection. These findings were consistent with those of gliomas. After discussing the options of surgical operation and stereotactic gamma knife radiosurgery (SGKR), the patient chose to proceed with radiosurgery. Stereotactic MRI was performed for planning the radiation dosage. One week later, the patient underwent SGKR. The tumor (volume, 5.7 ml) was covered with a 50% isodose gradient, and a 20-Gy dose was delivered to the tumor margin; the maximum dose was 40 Gy. The patient tolerated the procedure well and was discharged the same day. The tumor was very sensitive to SGKR and was completely absent on MRI scans obtained 8 months after SGKR (Figure 1B). Nevertheless, the partial seizures were still medically intractable. Eight months after radiosurgery, the patient remained neurologically intact. The adjacent brain tissue did not show any evidence of adverse effects of radiation. However, 4 months later, the patient was rehospitalized in the neurosurgical department because of a progressive headache and facial and right limb numbness as well as a partial seizure. MRI showed a recurrent mass lesion with moderate peripheral edema at the primary location (Figure 1C). Considering the recurrence, the tumor was radically resected. Some specimens were obtained during the surgery. Pathological studies of the surgical specimens showed that the tissue was hypercellular and was composed of pleomorphic round cells with a perinuclear halo and eosinophilic cytoplasm and without fibrillary background. Ganglion-like cells with large nuclei and fine cytoplasm were sparse. In some areas of the neurocytoma, the tumor cells were arranged as typical Homer-Wright rosettes, mimicking the appearance of ependymomas (Figure 1D, 1E). Mitotic figures were also observed. Immunohistochemical analysis showed that the solid components of the tumor cells were strongly and diffusely positive for Syn, CD56, and NF (Figure 1F). Immunoreactivity for glial fibrillary acidic protein (GFAP) was limited to reactive astrocytes. The Ki-67 labeling index was as high as 40% in the specimens (Figure 1G). Electron microscopy (EM) revealed that the tumor cells contained well-developed rough endoplasmic reticular (rER) vesicles, numerous clear vesicles, and dense core granules (Figure 1H, 1I). Synapse-like nerve terminal structures were also observed (Figure 1J). On the basis of the histological findings of the tumor and the patient's medical history, he was finally diagnosed with atypical EVN. The subsequent 1-year follow-up did not show any evidence of recurrence on serial CT and MRI scans. His epilepsy was also well controlled by medication, and he did not experience headaches and facial and right limb numbness after the operation. However, the patient died of pneumonia 1 year later.Figure 1. A:: Axial T1-weighted MRI scan showing a gadolinium-enhancing cystic mass lesion with extratumoral mural nodules in the left temporal lobe. B: The tumor completely disappeared 8 months after stereotactic gamma knife radiosurgery (SGKR). C, D: Axial T1- and T2-weighted MRI scans showing a recurrent mass lesion at the same location as the SGKR-treated lesion, with moderate peritumoral edema. E: Light microscopy image showing a tumor composed of pleomorphic round cells with perinuclear halo and eosinophilic cytoplasm (Evsion staining, original magnification ×200). F: Neurocytic rosettes of tumor cells surrounding an eosinophilic core (Evsion staining, original magnification ×200). G: Strong and diffuse immunoreaction for Syn both in the fibrillary matrix and in the perinuclear cytoplasm (Evsion staining, original magnification ×400). H: Ki-67-positive cells are frequently seen (Evsion staining, original magnification ×400). I: Electron microscopy image of the surgical specimens showing well-developed rough endoplasmic reticular vesicles, rich clear vesicles, and dense core granules (original magnification ×12 500). J: Dense core neurosecretory granules (original magnification ×8900). K: Synapse-like nerve terminal structures within tumor cells (original magnification ×24 000).The histological features of EVN and CN are similar and are characterized by monotonous populations of round-to-oval cells with scanty cytoplasm separated by the neuropil and branching capillaries. 2 In this case, light microscopy showed diffuse proliferation of monotonous tumor cells with perinuclear clearing within a delicate fibrillary matrix similar to the neuropil and also showed vascular proliferation and high mitotic activity. Immunohistochemically, these tumor cells were strongly positive for Syn both in the neuropil and in the perinuclear cytoplasm, and a limited number of cells were GFAP-positive. The Ki-67 labeling index was as high as 40%. These findings were compatible with those of EVN with histological atypia. Therefore, the patient was diagnosed with atypical EVN. Owing to the rarity of atypical EVN, the optimal treatment modality for these tumors has yet to be clearly established. According to the literature, complete resection is considered to be the best treatment for patients with typical neurocytomas; patients who are not eligible for complete resection can benefit from radiotherapy.3–5 Nevertheless, SGKR seemed to be a suitable choice for this patient, considering his age and health status. In the last decade, SGKR has been used for the management of CNs. The rationale for using SGKR for treating CNs is that a CN is well demarcated and relatively radiosensitive.3 On retrospectively reviewing the literature, we found 20 cases where CN patients were treated with SGKR, which suggested the efficacy of radiosurgery in the management of CN.3,5 In our patient, the atypical EVN disappeared 8 months after SGKR, indicating that the atypical EVN was sensitive to SGKR. However, the tumor recurred 1 year after SGKR. The Ki-67 labeling index of the tumor was as high as 40%; therefore, we assumed that the tumor recurred because of canceration. Kim et al4 analyzed 13 patients who had CN and underwent primary therapy or secondary postoperative therapy with SGKR, with a median MRI follow-up period of 61 months (range, 6-96 months). In this series, very good results were obtained with respect to SGKR and tolerability to SGKR. Matsunaga et al5 retrospectively reviewed 15 patients who had CN and underwent SGKR. He recommended SGKR for residual or recurrent tumors especially for early detection before tumor progression. In addition, he reported that a relatively low dose of not more than 20 Gy delivered to the tumor margin tended to control tumor growth well and reduced the risk of radiation injury.